CALIXAR will join the International Research Network (IRN) on GPCRs as a sponsor for the 2nd IRN I-GPCRNET Annual Meeting at the University of Wurzburg (Germany), from September 30th to October 1st, 2022.
Amélia CHORFA, post-doctoral at CALIXAR, will present during this event herPhD work carried out at the Institute of Functional Genomics in Montpellier in the team of Bernard Mouillac and Sébastien Granier.
She worked on the characterization of effects of Mambaquaretin (toxin from green mamba venom) on renal cancer by targeting Vasopressin type 2 receptor (V2R), a GPCR responsible to antidiuresis. By in vitro and in vivo models, she shown that Mambaquaretin is a new potential molecule candidate for diagnosis and treatment for renal cancer.
Amélia is currently working with Ralf Jocker’s team (Cochin Institute -INSERM Paris) and with CALIXAR team in Lyon on GPR50 and others GPCR targets.
CALIXAR as expert in the field of native and functional GPCRs expression and isolation supports and encourages research on GPCR targets. The most talented poster of this session will receive the poster prize 2022 awarded by CALIXAR.
The i-GPCRnet International Research Network (IRN) was founded in 2021 for five years by the CNRS (www.cnrs.fr), the National Centre for Scientific Research of France, an interdisciplinary public research organization that is among the world’s leading research institutions.
The mission of the i-GPCRnet IRN is to promote science in the field of G protein-coupled receptors (GPCRs).
For more information and meet us: i-GPCRnet